Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.38 |
| ▸ | TPSD1 | Q9BZJ3 | 2/20 | 0.38 |
| ▸ | TPSG1 | Q9NRR2 | 2/20 | 0.38 |
| ▸ | TLR2 | O60603 | 4/20 | 0.37 |
| ▸ | TLR1 | Q15399 | 2/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | EPOR | P19235 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25355565 | 0.96 | KMT2A (0.44) | KMT2AFOLH1TPSAB1TPSD1TPSG1 | |
| SCHEMBL25355567 | 0.96 | KMT2A (0.44) | KMT2AFOLH1TPSAB1TPSD1TPSG1 | |
| SCHEMBL31714214 | 0.92 | KMT2A (0.43) | KMT2AFOLH1TPSAB1TPSD1TPSG1 | |
| SCHEMBL25358215 | 0.90 | KMT2A (0.39) | KMT2AFOLH1TLR2MDM2 | |
| SCHEMBL25358208 | 0.90 | KMT2A (0.39) | KMT2AFOLH1TLR2MDM2 | |
| SCHEMBL29401577 | 0.88 | KMT2A (0.50) | KMT2AFOLH1TPSAB1TPSD1TPSG1 | |
| SCHEMBL25354987 | 0.88 | KMT2A (0.50) | KMT2AFOLH1TPSAB1TPSD1TPSG1 | |
| SCHEMBL25354991 | 0.88 | KMT2A (0.50) | KMT2AFOLH1TPSAB1TPSD1TPSG1 | |
| SCHEMBL31688635 | 0.87 | KMT2A (0.52) | KMT2AFOLH1TPSAB1TPSD1TPSG1 | |
| SCHEMBL25356972 | 0.86 | KMT2A (0.44) | KMT2AFOLH1TPSAB1TPSD1TPSG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | claimed |
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | KMT2A 2979/4885FOLH1 239/4885TPSAB1 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.